Related Experiment Video
Updated: Dec 13, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Knowledge and Attitudes of Canadian Cardiac Surgeons Regarding Patients With Human Immunodeficiency Virus
Karan Bami1, Shrankhala Tewari2, Paul A MacPherson3
1Division of Cardiology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Insights
Cardiac surgeons widely accept patients with controlled human immunodeficiency virus (HIV) for valve and bypass surgeries. However, most view HIV as a barrier to heart transplantation, indicating a need for updated guidelines and evidence.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Practice
Background:
- Limited data exist on current cardiac surgical practices for individuals with human immunodeficiency virus (HIV).
- Surgeons' perceptions regarding the suitability of HIV-positive patients for various cardiac procedures are not well-documented.
Purpose of the Study:
- To assess Canadian cardiac surgeons' perceptions of eligibility for a full spectrum of cardiac surgeries in patients with human immunodeficiency virus (HIV).
- To evaluate current clinical viewpoints on managing cardiac conditions in the context of controlled HIV infection.
Main Methods:
- A prospective survey was administered to 155 cardiac surgeons across Canada.
- Surgeons' eligibility assessments for cardiac procedures were evaluated using clinical scenarios involving patients with well-controlled HIV.
Main Results:
- Of 63 respondents, a majority deemed patients with controlled HIV eligible for valve replacement (73%), valve repair (74.6%), and coronary artery bypass graft (CABG) surgery (79.4%).
- Few surgeons considered HIV-positive patients candidates for cardiac transplantation (7.9%) or as potential donors (1.6%).
- Opinions were divided regarding the use of ventricular assist devices (VADs) in this population.
Conclusions:
- Most cardiac surgeons are willing to perform conventional cardiac surgeries like CABG and valve procedures on patients with effectively managed HIV.
- HIV status is largely perceived as a contraindication for cardiac transplantation, suggesting a gap in current understanding or practice.
- There is a clear need for further medical education and robust evidence to guide cardiac surgical decisions for patients living with HIV.
Background:
Current data on cardiac surgical practices for people living with human immunodeficiency virus (HIV) are lacking. We hypothesized that cardiac surgeons would consider people living with HIV as candidates for the full scope of cardiac surgery, including heart transplant for these patients.
Methods:
We conducted a prospective survey of 155 cardiac surgeons across Canada to evaluate their current clinical perceptions regarding cardiac surgery in people living with HIV. Specifically, we evaluated their assessment of eligibility toward a wide scope of cardiac surgeries by using representative clinical scenarios.
Results:
A total of 63 surgeon responses (40.6%) were completed. The majority of surgeons agreed that a 50-year-old man with HIV and no other comorbidities, who had been receiving combination antiretroviral therapy for 5 years with an undetectable viral load since starting therapy and a CD4 count greater than 350 cells/μL, would be a candidate for valve replacement (73%), valve repair surgery (74.6%), or coronary artery bypass graft surgery (79.4%). Few surgeons believed that this patient would be eligible for cardiac transplantation (7.9%) or could be a cardiac transplant donor (1.6%). There was clinical equipoise over the eligibility for ventricular assist device surgery.
Conclusions:
A majority of cardiac surgeons would perform coronary artery bypass graft surgery or valve surgery on patients with controlled HIV, but most consider HIV status as a prohibitive risk factor for cardiac transplantation. Although this may represent an opportunity for continuing medical education for cardiac surgeons, it also highlights the need for contemporary, high-quality evidence in this patient population.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Sexually Transmitted Infections
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis III: Medical Management